Incidence of thymoma in myasthenia gravis: A systematic review

Journal of Clinical Neurology (Korea)

Volumn 8, Issue 3, 2012, Pages 161-169

  Mao, Zhi Feng ^a   Mo, Xue An ^a   Qin, Chao ^a   Lai, Yong Rong ^a   Hackett, Maree L ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Incidence; Myasthenia; Systematic review; Thymoma

Indexed keywords

EID: 84867189684     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2012.8.3.161     Document Type: Article

References (63)

1. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol 1999;17:2280-2289.
2. Potagas C, Dellatolas G, Tavernarakis A, Molari H, Mourtzouhou P, Koutra H, et al. Myasthenia gravis: changes observed in a 30-years retrospective clinical study of a hospital-based population. J Neurol 2004;251:116-117.
3. Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-1127.
4. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
5. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009;8:1006-1018.
6. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005; 36:1330-1340.
7. Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008;149:123-134.
8. Romi F. Thymoma in myasthenia gravis: from diagnosis to treatment. Autoimmune Dis 2011;2011:474512.
9. Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci 1966;135:496-505.
10. Oosterhuis HJ, de Haas WH. Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clinical investigation. Acta Neurol Scand 1968;44:219-227.
11. Mulder DG, Herrmann C Jr, Keesey J, Edwards H. Thymectomy for myasthenia gravis. Am J Surg 1983;146:61-66.
12. Monden Y, Uyama T, Nakahara K, Fujii Y, Hashimoto J, Ohno K, et al. Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann Thorac Surg 1986;41:189-192.
13. Papatestas AE, Genkins G, Kornfeld P, Eisenkraft JB, Fagerstrom RP, Pozner J, et al. Effects of thymectomy in myasthenia gravis. Ann Surg 1987;206:79-88.
14. Giagheddu M, Puggioni G, Sanna G, Tamburini G, Marrosu F, Rachele MG, et al. Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand 1989;79:326-333.
15. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Th-ymectomy in myasthenia gravis. Results of 662 cases operated upon in 15 years. Eur J Cardiothorac Surg 1989; 3: 504-509. discussion 510-511.
16. Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989;80:290-295.
17. Tola MR, Granieri E, Paolino E, Caniatti L, Quatrale R, Mazzanti B, et al. Epidemiological study of myasthenia gravis in the province of Ferrara, Italy. J Neurol 1989;236:388-390.
18. Mantegazza R, Beghi E, Pareyson D, Antozzi C, Peluchetti D, Sghirlanzoni A, et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990;237:339-344.
19. Ferrari G, Lovaste MG. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology 1992;11:135-142.
20. Yu YL, Hawkins BR, Ip MS, Wong V, Woo E. Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 1992;86:113-119.
21. Antonini G, Morino S, Gragnani F, Fiorelli M. Myasthenia gravis in the elderly: a hospital based study. Acta Neurol Scand 1996;93:260-262.
22. Masaoka A, Yamakawa Y, Niwa H, Fukai I, Kondo S, Kobayashi M, et al. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 1996;62:853-859.
23. Nicolaou S, Müller NL, Li DK, Oger JJ. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology 1996;201:471-474.
24. Aiello I, Pastorino M, Sotgiu S, Pirastru MI, Sau GF, Sanna G, et al. Epidemiology of myasthenia gravis in northwestern Sardinia. Neuroepidemiology 1997;16:199-206.
25. Beekman R, Kuks JB, Oosterhuis HJ. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 1997;244:112-118.
26. Bulkley GB, Bass KN, Stephenson GR, Diener-West M, George S, Reilly PA, et al. Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 1997; 226: 324-334. discussion 334-335.
27. Cosi V, Romani A, Lombardi M, Raiola E, Bergamaschi R, Piccolo G, et al. Prognosis of myasthenia gravis: a retrospective study of 380 patients. J Neurol 1997;244:548-555.
28. Christensen PB, Jensen TS, Tsiropoulos I, Sørensen T, Kjaer M, Højer-Pedersen E, et al. Mortality and survival in myasthenia gravis: a Danish population based study. J Neurol Neurosurg Psychiatry 1998;64: 78-83.
29. Guidetti D, Sabadini R, Bondavalli M, Cavalletti S, Lodesani M, Mantegazza R, et al. Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol 1998;14:381-387.
30. Robertson NP, Deans J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998;65:492-496.
31. Lavrnić D, Jarebinski M, Rakocević-Stojanović V, Stević Z, Lavrnić S, Pavlović S, et al. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Sc-and 1999;100:168-174.
32. Holtsema H, Mourik J, Rico RE, Falconi JR, Kuks JB, Oosterhuis HJ. Myasthenia gravis on the Dutch antilles: an epidemiological study. Clin Neurol Neurosurg 2000;102:195-198.
33. Abt PL, Patel HJ, Marsh A, Schwartz SI. Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experi-ence. J Am Coll Surg 2001;192:459-464.
34. Budde JM, Morris CD, Gal AA, Mansour KA, Miller JI Jr. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg 2001;72:197-202.
35. Fink JN, Wallis WE, Haydock DA. Myasthenia gravis with thymoma is more common in the Maori and Pacific Island populations in New Zealand. Intern Med J 2001;31:206-210.
36. Mussi A, Lucchi M, Murri L, Ricciardi R, Luchini L, Angeletti CA. Extended thymectomy in myasthenia gravis: a team-work of neurologist, thoracic surgeon and anaesthesist may improve the outcome. Eur J Cardiothorac Surg 2001;19:570-575.
37. de Perrot M, Liu J, Bril V, McRae K, Bezjak A, Keshavjee SH. Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg 2002;74:1658-1662.
38. Rastenyte D, Vaitkus A, Neverauskas R, Pauza V. Demographic and clinical characteristics of patients with myasthenia gravis. Medicina (Kaunas) 2002;38:611-616.
39. Remes-Troche JM, Téllez-Zenteno JF, Estañol B, Garduño-Espinoza J, García-Ramos G. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch Med Res 2002;33:545-551.
40. Roth T, Ackermann R, Stein R, Inderbitzi R, Rösler K, Schmid RA. Thirteen years follow-up after radical transsternal thymectomy for myasthenia gravis. Do short-term results predict long-term outcome? Eur J Cardiothorac Surg 2002;21:664-670.
41. Au WL, Das A, Tjia HT. Myasthenia gravis in Singapore. Neurol J Southeast Asia 2003;8:35-40.
42. Wirtz PW, Nijnuis MG, Sotodeh M, Willems LN, Brahim JJ, Putter H, et al. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. J Neurol 2003;250:698-701.
43. Casetta I, Fallica E, Govoni V, Azzini C, Tola M, Granieri E. Incid-ence of myasthenia gravis in the province of Ferrara: a community-based study. Neuroepidemiology 2004;23:281-284.
44. Yasukawa Y, Yoshikawa H, Iwasa K, Yamada M, Takamori M. Comparative study of pre-operative thymic imaging and pathology in patients with myasthenia gravis. J Clin Neurosci 2004;11:610-613.
45. Huang CS, Hsu HS, Huang BS, Lee HC, Kao KP, Hsu WH, et al. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis. Acta Neurol Scand 2005;112:108-114.
46. Matsuda M, Dohi-Iijima N, Nakamura A, Sekijima Y, Morita H, Matsuzawa S, et al. Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med 2005; 44:572-577.
47. Levin N, Abramsky O, Lossos A, Karussis D, Siegal T, Argov Z, et al. Extrathymic malignancies in patients with myasthenia gravis. J Neurol Sci 2005;237:39-43.
48. Suzuki S, Shimoda M, Kawamura M, Sato H, Nogawa S, Tanaka K, et al. Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects. Eur J Neurol 2005;12:566-570.
49. Aghajanzadeh M, Khoshrang H, Mohammadzadeh A, Roudbari SA, Ghayeghran AR. Thymectomy for myasthenia gravis: prognostic factors in 70 patients. Asian Cardiovasc Thorac Ann 2007;15:371-375.
50. Kim HK, Park MS, Choi YS, Kim K, Shim YM, Han J, et al. Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma. J Thorac Cardiovasc Surg 2007; 134:601-607.
51. Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry 2007; 78:1109-1112.
52. Al-Moallem MA, Alkali NH, Hakami MA, Zaidan RM. Myasthenia gravis: presentation and outcome in 104 patients managed in a single institution. Ann Saudi Med 2008;28:341-345.
53. Singhal BS, Bhatia NS, Umesh T, Menon S. Myasthenia gravis: a study from India. Neurol India 2008;56:352-355.
54. Citterio A, Beghi E, Millul A, Evoli A, Mantegazza R, Antozzi C, et al. Risk factors for tumor occurrence in patients with myasthenia gravis. J Neurol 2009;256:1221-1227.
55. Matsui N, Nakane S, Nakagawa Y, Kondo K, Mitsui T, Matsumoto T, et al. Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J Neurol Neurosurg Psychiatry 2009; 80:1168-1171.
56. Chmura Kraemer H, Periyakoil VS, Noda A. Kappa coefficients in medical research. Stat Med 2002;21:2109-2129.
57. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48:2485-2492.
58. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006;81:2328-2334.
59. Voltz RD, Albrich WC, Nägele A, Schumm F, Wick M, Freiburg A, et al. Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology 1997;49: 1454-1457.
60. Chen XJ, Qiao J, Xiao BG, Lu CZ. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis. J Neurol 2004;251:1006-1011.
61. Giraud M, Vandiedonck C, Garchon HJ. Genetic factors in autoimmune myasthenia gravis. Ann N Y Acad Sci 2008;1132:180-192.
62. Tomaszek S, Wigle DA, Keshavjee S, Fischer S. Thymomas: review of current clinical practice. Ann Thorac Surg 2009;87:1973-1980.
63. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009;8:475-490.